Serious adverse events · children aged 5 to 11 years
1 finding from 1 review
BMI short‐term (12 weeks from baseline to < 9 months) · children aged 5 to 11 years
1 finding from 1 review
Body‐mass index (BMI) · children aged 12 to 18 years
3 findings from 1 review
no estimate extracted
1 study · 985 participants
Low
no estimate extracted
6 studies · 1780 participants
Low
no estimate extracted
3 studies · 2143 participants
Low
zBMI short term (12 weeks from baseline to < 9 months) · children aged 12 to 18 years
1 finding from 1 review
zBMI medium term (9 months to < 15 months) · children aged 12 to 18 years
1 finding from 1 review
zBMI long term (> 15 months) · children aged 12 to 18 years
1 finding from 1 review
Serious adverse events · children aged 12 to 18 years
1 finding from 1 review
Primary outcome · spatial neglect or inattention following stroke and other adult‐acquired non‐progressive brain injury
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Secondary outcomes · spatial neglect or inattention following stroke and other adult‐acquired non‐progressive brain injury
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neglect outcomes: immediate effects · spatial neglect or inattention following stroke and other adult‐acquired non‐progressive brain injury
It is very uncertain whether movement interventions changes neglect outcomes: immediate effects compared with any control (very low certainty).
1 finding from 1 review
Adverse events · spatial neglect or inattention following stroke and other adult‐acquired non‐progressive brain injury
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Depression: meeting study criteria for depression at end of · people with depression after stroke
Pharmacological intervention and non‐invasive brain stimulation… may leads to lower depression: meeting the criteria for depression at end of treatment… compared with a pharmacological intervention and sham stimulation or usual care… (low certainty).
2 findings from 1 review
Depression: < 50% reduction in scale scores at end of treatment (primary outcome) · people with depression after stroke
It is very uncertain whether pharmacological intervention and non‐invasive brain stimulation… changes depression: < 50% reduction in scale scores at end of treatment… compared with a pharmacological intervention and sham stimulation or usual care… (very low certainty).
1 finding from 1 review
Depression: mean scores at end of treatment (secondary outcome) · people with depression after stroke
1 finding from 1 review
Adverse events: death ‐ at end of treatment (secondary outcome) · people with depression after stroke
It is very uncertain whether pharmacological intervention and non‐invasive brain stimulation… changes adverse events: death (secondary outcome) compared with a pharmacological intervention and sham stimulation or usual care… (very low certainty).
1 finding from 1 review
Adverse events: all ‐ central nervous system events (e.g. headache, seizures) (secondary outcome) · people with depression after stroke
It is very uncertain whether pharmacological intervention and non‐invasive brain stimulation… changes adverse events: all ‐ central nervous system events (e.g. headache,… compared with a pharmacological intervention and sham stimulation or usual care… (very low certainty).
1 finding from 1 review
Adverse events: all ‐ other events ‐ not listed above (e.g. dysuria, neck pain, eye discomfort) (secondary outcome) · people with depression after stroke
It is very uncertain whether pharmacological intervention and non‐invasive brain stimulation… changes adverse events: all ‐ other events ‐ not listed above (e.g.… compared with a pharmacological intervention and sham stimulation or usual care… (very low certainty).
1 finding from 1 review
Stress symptoms ( · healthcare workers
3 findings from 1 review
no estimate extracted
35 studies · 2366 participants
Low
no estimate extracted
6 studies · 427 participants
Low
no estimate extracted
0 studies · 0 participants
GRADE not reported
Exacerbations: number of people experiencing moderate or severe exacerbations · treatment for asthma in adults and children with asthma and GORD
Medical or surgical intervention, or both, for gastro‐oesophageal… showed no clear difference in number of participants with moderate/severe acute exacerbations… compared with nil intervention, delayed intervention control, or placebo (low certainty).
1 finding from 1 review
Lung function: FEV1 mL (change from baseline) · treatment for asthma in adults and children with asthma and GORD
1 finding from 1 review